The Emerging Profile of Immunotherapy Approaches in the Treatment of AML

Dr. Daver discusses immunotherapy approaches for patients with acute myeloid leukemia (AML), and his recent study results on the combination of azacitidine and nivolumab.

Source: CancerNetwork - January 17, 2019 Category: Cancer & Oncology Authors: Naval Daver, MD Source Type: news